Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04745000 · ClinicalTrials.gov registry record
Observational Study of Actigraphy in Pediatric Pulmonary Arterial Hypertension
A clinical trial of Hypertension;Pulmonary;Primary, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 43
- Enrollment target
- 1
- Study location
NCT04745000: Completed study of Hypertension;Pulmonary;Primary, sponsored by University of Colorado, Denver.
NCT04745000 is a study of Hypertension;Pulmonary;Primary that has completed, run by University of Colorado, Denver. The registered enrollment target is 43 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04745000, a study of Hypertension;Pulmonary;Primary, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
This study plans to learn more about activity levels in children with pulmonary hypertension. Pulmonary hypertension is a condition where the pressure in the lungs is higher than normal. This can affect the person's heart. The purpose of this study is to see if measuring activity in children with pulmonary hypertension and comparing it to activity in children without pulmonary hypertension can give their doctor helpful information on how they are feeling and how their treatment is working.
Primary Outcome
Actigraphy device wear compliance threshold is a minimum of 4 hours per day, and 8 compliant days out of 14 days of wear time.
Conditions Studied
Study Locations (1)
Colorado
- Children's Hospital Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2021-02-11 |
| Est. Completion | 2022-04-14 |
What the finished NCT04745000 record still lists
NCT04745000 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target.
The record links to 1 condition, with Hypertension;Pulmonary;Primary appearing as the primary indexed condition, and to 0 interventions.
NCT04745000 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT04745000 about?
NCT04745000 is a clinical study titled "Observational Study of Actigraphy in Pediatric Pulmonary Arterial Hypertension". This study plans to learn more about activity levels in children with pulmonary hypertension. Pulmonary hypertension is a condition where the pressure in the lungs is higher than normal. This can affect the person's heart. The purpose of this study is to see if measuring activity in children with pu...
What is the current status of trial NCT04745000?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2021-02-11. Estimated completion is 2022-04-14.
What conditions does trial NCT04745000 study?
This clinical trial studies the following conditions: Hypertension;Pulmonary;Primary.
Who is sponsoring clinical trial NCT04745000?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04745000 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI